Photo of Shane O. Rogosin, MD
4.8
162 Ratings

Shane O. Rogosin, MD

Accepting New Patients
Offers Video Visits
1500 Division Street, Suite 220
Oregon City, OR 97045
2320.5 miles away
Speaks: English
map

Providence Cancer Institute - Willamette Falls

1500 Division Street, Suite 220, Oregon City, OR 97045

Are you covered?

Check to see if your insurance is covered by this provider.

About Shane O. Rogosin

Dr. Rogosin is a physician trained in internal medicine with additional specialty training in oncology and hematology. He sees patients with blood disorders and cancer in Oregon City, Oregon. Dr. Rogosin is a native to Oregon, having grown up in Salem, Oregon, and completed all of his medical training including medical school, residency, and fellowship at Oregon Health & Science University. He has always felt deeply connected to the people of his community and feels that it is an honor to serve them.

When not seeing patients, Dr. Rogosin enjoys spending time in the outdoors doing such activities as hiking, skiing and biking or spending time with his wife and two children. Dr. Rogosin is board-certified in internal medicine, hematology and oncology and is associated with Providence Cancer Institute.

Fellowship

Oregon Health Sciences University
2011

Medical School

Oregon Health Sciences University
2004

Residency

Oregon Health Sciences University
2007

Board Certifications
  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Medical Oncology
Providence Cancer Institute - Willamette Falls
1500 Division Street, Suite 220
Oregon City, OR 97045

Affiliated Locations
Providence Hood River Memorial Hospital
Providence Willamette Falls Medical Center
Providence St. Vincent Medical Center
Providence Newberg Medical Center
Providence Milwaukie Hospital
Providence Portland Medical Center
Providence Seaside Hospital

Clinical Interests

  • Anal Cancer
  • Anal Cancer Chemotherapy
  • Anaplastic Meningioma
  • Anorectal Cancer
  • Anorectal Cancer Chemotherapy
  • Atypical Ductal Hyperplasia
  • Atypical Meningioma
  • Bladder Cancer
  • Bladder Cancer Genomics
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoid Tumor
  • Carcinoma In Situ Of Breast
  • Carcinoma Of Unknown Primary
  • Cervical Cancer Genomics
  • Chemoradiation
  • Chest Wall Tumors
  • Cholangiocarcinoma
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer
  • Colon Cancer Genomics
  • Colorectal Cancer
  • Colorectal Cancer Chemotherapy
  • Crizotinib
  • Ductal Carcinoma In Situ (Dcis)
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Esophageal Cancer
  • Esophageal Cancer Chemotherapy
  • Fibrous Meningioma
  • Gallbladder Cancer
  • Gallbladder Cancer Genomics
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Genomics
  • Hematologic Malignancies
  • Hemochromatosis
  • Hereditary Breast And Ovarian Cancer
  • Histiocytic Sarcoma
  • Hypopharyngeal Cancer
  • Immature Teratoma
  • Islet Cell Tumor
  • Kidney Cancer
  • Laryngeal Cancer
  • Leukemia
  • Leukemia Genomics
  • Liver Cancer Genomics
  • Lobular Carcinoma In Situ (Lcis)
  • Lung Cancer
  • Lung Cancer Genomics
  • Lung Metastasis
  • Lymphedema Therapy
  • Lymphoma
  • Lymphoma Genomics
  • Lynch Syndrome
  • Male Breast Cancer
  • Malignant Neoplasm Of Esophagus
  • Malignant Neoplasm Of Liver
  • Mediastinal Mass
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Mesothelioma
  • Metastatic Liver Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • Metastatic Tumors To The Lungs
  • Mouth Cancer
  • Mucosal Melanoma
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Nasopharyngeal Cancer
  • Neoplasm Of Salivary Gland
  • Neuroendocrine Tumors
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Oral Complications Of Cancer
  • Oral Lesions
  • Oropharyngeal Cancer
  • Ovarian Cancer
  • Pancreas Cancer
  • Pancreatic Cancer Genomics
  • Paranasal Sinus And Nasal Cavity Cancer
  • Plasma Cell Dyscrasia
  • Polycythemia
  • Primary Myelofibrosis
  • Prostate Cancer
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rectal Cancer Genomics
  • Renal Cancer Genomics
  • Retroperitoneal Mass
  • Sarcoma Genomics
  • Side Effects Of Cancer Treatment
  • Skin Cancer Genomics
  • Small Bowel Cancer
  • Small Cell Lung Cancer
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Stomach Cancer Chemotherapy
  • Stomach Cancer Genomics
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Thoracic Cancer
  • Thoracic Malignancy
  • Thrombocytopenia
  • Thyroid Cancer Genomics
  • Tongue Cancer
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vaginal Melanoma
  • Virtual Care